GSK3B and Parkinson disease: Likewise, 6-hydroxydopamine (6-OHDA)-induced in vitro and in vivo models of PD have demonstrated elevated levels of LRRK2 and GSK3β, the two kinases directly involved in the formation of tau and α-synuclein proteins, causing PD [370].